Is Teriparatide legal in Australia?

Teriparatide in Australia at a glance

Classification and note come from the Teriparatide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

• 01

  TGA has approved Teriparatide for at least one labeled indication, so a pharmaceutical-grade product exists in Australia and is dispensed on prescription.

• 02

  Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.

• 03

  Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.

What Teriparatide is

An FDA-approved bone-building peptide, a fragment of parathyroid hormone used for severe osteoporosis.

Teriparatide is the active 1-34 fragment of parathyroid hormone, approved as Forteo for osteoporosis at high fracture risk. Unlike most osteoporosis drugs that slow bone loss, teriparatide actively builds new bone when given as a once-daily injection.

Mechanism: Intermittent activation of PTH receptors stimulates bone-forming osteoblasts, increasing bone density and strength.

Regulatory history: FDA-approved (Forteo) for osteoporosis

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Teriparatide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Teriparatide in other countries

Frequently asked questions

Related compounds in Australia